Join the club for FREE to access the whole archive and other member benefits.


Nanovery is developing nanorobots to diagnose diseases.

Our nanorobots are added to blood samples. When they capture a cancer biomarker they light up, allowing point-of-care testing. As there is no need for high capital expenditure, our nanorobots are 10 times cheaper. The whole process is also more than 100 times faster – a matter of one or two hours rather than weeks – as there is no need for complex lab protocols which require bioinformaticians to analyse the data.

Visit website:


Details last updated 12-Nov-2019

People at Nanovery

Jurek Kozyra

Founder of Nanovery

Jerzy Kozyra

Founder of Nanovery.

Nanovery News

Nanovery raise 1.85M-develop nanorobots that can detect biomarkers directly in blood serum samples

Digital Health - 11-Apr-2023

Nanorobots make the process cost-efficient and fast, with same level of accuracy compared to tradition method


Nanobots - potential superheroes in the war against cancer

Sifted - 26-Aug-2019

There's a chance for at least one of these novel approaches might work

Topics mentioned on this page: